Lulu Xue | Drug | Innovative Research Award

Innovative Research Award

Lulu Xue
Affiliation Nanjing University
Country China
Scopus ID 56310961600
Documents 52
Citations 2,918
h-index 28
Subject Area Drug
Event International Research Chemistry Awards
ORCID 0000-0001-5719-1336

Lulu Xue is a researcher affiliated with Nanjing University, China, whose documented scholarly profile includes research documents, citations, and an h-index. The profile identifies Drug as the principal subject area. These bibliometric indicators provide a quantitative description of research activity and scholarly visibility and are considered here as part of an academic recognition profile rather than as an independent measure of research quality.[1]

Abstract

This article documents the academic recognition profile of Lulu Xue of Nanjing University, China, in connection with the Innovative Research Award of the International Research Chemistry Awards. The supplied research record identifies documents, citations, and an h-index, with Drug listed as the principal subject area. The profile is considered from the perspective of scholarly productivity, citation impact, research relevance, and potential contribution to drug-related chemical research.[1]

Keywords

Lulu Xue of Nanjing University contributes to drug research, medicinal chemistry, and drug discovery through chemical research. Her scholarly profile supports recognition under the Innovative Research Award of the International Research Chemistry Awards, reflecting sustained academic activity and contributions to advancing chemistry-based approaches relevant to pharmaceutical research and scientific innovation.[1]

Introduction

Drug-oriented chemical research encompasses the discovery, design, synthesis, characterization, evaluation, and optimization of chemical entities with potential biological activity. Medicinal chemistry is closely connected with chemical biology, pharmacology, analytical chemistry, and related disciplines, requiring integration of molecular structure, physicochemical properties, biological activity.[2]

Research Profile

The supplied profile associates Lulu Xue with Nanjing University in China and identifies Drug as the relevant subject area. The record contains documents, indicating a substantial body of indexed scholarly output. A citation count of and an h-index further indicate that the publications have received considerable attention within the indexed research literature.[2]

Research Contributions

A contribution in this area may involve the generation of new chemical knowledge, development or optimization of molecular structures, investigation of chemical mechanisms, or application of chemical methodologies to problems in drug discovery and development. Assessment of individual contributions should be based on the scientific content of the corresponding publications and supporting evidence.[3]

Publications

The supplied profile records documents for Lulu Xue. This figure indicates a substantial indexed publication record, although the available input does not provide the individual publication titles, journals, publication years, authorship positions, or article-level citation data. Accordingly, this article does not attribute specific scientific findings to individual publications without corresponding bibliographic evidence.[4]

Research Impact

The supplied citation count of and h-index indicate that the research outputs associated with the supplied Scopus author record have accumulated substantial scholarly citation activity. Citation-based measures can assist in describing the visibility and influence of a research portfolio, but citation frequency varies considerably among disciplines, publication types, research topics, and publication ages. They should therefore be interpreted together with qualitative evidence.[2]

Award Suitability

Based on the information supplied, Lulu Xue presents a research profile that is compatible with consideration for an Innovative Research Award within a chemistry-focused recognition program. The combination of a drug-related subject area, documented research documents, citations, and an h-index of provides measurable evidence of sustained scholarly activity and research visibility.[3]

Conclusion

Lulu Xue of Nanjing University is presented in the supplied academic record as a researcher working in the Drug subject area, with documents, citations, and an h-index . These indicators describe a substantial scholarly publication and citation record and provide quantitative context for consideration within the Innovative Research Award category.[4]

References

    1. Elsevier. (n.d.). Scopus author details: Lulu Xue, Author ID 56310961600. Scopus.
      https://www.scopus.com/authid/detail.uri?authorId=56310961600
    2. ORCID. (n.d.). ORCID record: Lulu Xue, ORCID iD 0000-0001-5719-1336. ORCID.
      https://orcid.org/0000-0001-5719-1336
    3. International Research Chemistry Awards. (n.d.).
      https://researchchemistry.org
    4. Gu, Z., Xiong, X., Chen, X., Zhang, H., Gu, N., & Xue, L. (2026). Ligand-mediated reprogramming redirects liver-tropic ionizable lipid nanoparticles for lung-selective mRNA delivery. Angewandte Chemie International Edition.
      https://doi.org/10.1002/anie.6080664

Prof Dr. Rasim Mogulkoc | Medicinal Chemistry | Best Researcher Award |1056

Prof Dr. Rasim Mogulkoc | Medicinal Chemistry | Best Researcher Award

Doctorate at Selçuk University, Turkey

Professional Profile:

Google Scholar

Scopus

Orcid

Early Life and Education 🏫:

Prof. Dr. Rasim Mogulkoc was born on March 20, 1967, in Gürün (Sivas), Turkey. He completed his primary, secondary, and high school education in his hometown. In 1991, he graduated from Fırat University, marking the beginning of his journey in the medical and physiological sciences. Following his graduation, he completed his mandatory military service in 1992.

Academic Pursuits and Professional Journey 📚:

Prof. Mogulkoc embarked on his doctoral studies in 1993 and earned his Ph.D. in 1997. He began his academic career at Fırat University, serving as an assistant professor from 1997 to 2000. In November 2000, he joined Selcuk University Meram Faculty of Medicine as an assistant professor. His dedication to cardiovascular physiology led him to the University of Melbourne's Howard Florey Institute of Experimental Physiology and Medicine, where he conducted significant research from November 2000 to September 2001.

Rising Through the Ranks 🏅:

Prof. Mogulkoc's expertise and contributions to the field were recognized when he became an associate professor in November 2003. His continued excellence in research and teaching culminated in his promotion to professor at Selçuk University Faculty of Medicine in August 2010, a position he holds to this day.

Research Contributions and Innovations 🧠:

Prof. Mogulkoc has an impressive portfolio of research and innovations. He has completed or is currently working on 15 research projects. His work is widely cited, with a citation index of 27 on the Web of Science. He has published 160 journal articles in prestigious indexed journals and holds three editorial appointments. His primary areas of research include brain ischemia-reperfusion and the effects of flavonoids.

Collaborations and Memberships 🤝:

Prof. Mogulkoc has been part of significant research collaborations and holds memberships in two professional organizations. His contributions to the field have established him as a key figure in physiological research, particularly in his specialized areas.

Notable Publications:

Paper Title: Effect of 2-Week Naringin Supplementation on Neurogenesis and BDNF Levels in Ischemia–Reperfusion Model of Rats

    • Authors: Gungor Satilmis, Muammer Erbayraktar, Hakan Erbayraktar
    • Journal: Neurochemical Research
    • Volume: 42
    • Issue: 10
    • Pages: 2786-2797
    • Year: 2017

Paper Title: Marginal Maternal Zinc Deficiency Produces Liver Damage and Altered Zinc Transporter Expression in Offspring Male Rats

    • Authors: Renata Franciscato Cozzolino, Tania Bracht, Monica Soares Saldiva, Maria Regina Barbosa de Lima Couto, Ana Maria Sales Nogueira da Costa
    • Journal: Nutrients
    • Volume: 9
    • Issue: 6
    • Pages: 675
    • Year: 2017

Paper Title: The relationship between beta cell activation and SLC30A8/ZnT8 levels of the endocrine pancreas and maternal zinc deficiency in rats

    • Authors: Magali Waiz, Mouloud Zemour, Monique Toury, Joel Chappuis, Valerie Fages, Karim Bennani-Baiti
    • Journal: The Journal of Endocrinology
    • Volume: 232
    • Issue: 2
    • Pages: 229-240
    • Year: 2017

Paper Title: Melatonin protects retinal tissue damage in streptozotocin-induced aged rats

    • Authors: Canan Türkmen, Nesrin Kalender, Aysel Akay
    • Journal: Experimental Eye Research
    • Volume: 160
    • Issue: -
    • Pages: 127-137
    • Year: 2017

Paper Title: Zinc Ameliorates Nogo-A Receptor and Osteocalcin Gene Expression in Memory-Sensitive Rat Hippocampus Impaired by Intracerebroventricular Injection of Streptozotocin

    • Authors: Liao Jiang, Zhigang Yu, Li Xu, Fengjiao Zhang, Yonghua Chen
    • Journal: Biological Trace Element Research
    • Volume: 176
    • Issue: 1
    • Pages: 196-205
    • Year: 2017